Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: Immunotherapies are modern treatment modalities, giving hope for improvements of frozen cure rates in many childhood malignancies. More intensive cytotoxic chemotherapy cycles didn’t improve cure rates, only increase number of adverse events. Blinatumomab, a bispecific CD3/CD19 antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawinska-Wasikowska, Katarzyna, Wieczorek, Aleksandra, Balwierz, Walentyna, Bukowska-Strakova, Karolina, Surman, Marta, Skoczen, Szymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773605/
https://www.ncbi.nlm.nih.gov/pubmed/35053619
http://dx.doi.org/10.3390/cancers14020458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773605/
https://www.ncbi.nlm.nih.gov/pubmed/35053619
http://dx.doi.org/10.3390/cancers14020458

Ejemplares similares